cancer

January 5th, 2022· 1.9 min·
PolarisQB and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated